A preprint of the results were released last month, which revealed that all three vaccine formulations in the trial resulted in 'robust immune responses'.
Both Bharat Biotech and SII released factsheets indicating which categories of people should be exempted from the list of beneficiaries. See the full list here.
Out of the 45 lakh doses, over 8 lakh will be supplied to friendly countries such as Mauritius, Philippines and Myanmar, free of cost as a goodwill gesture.
Doctors in Assam, Maharashtra, Haryana say there’s no reason to not take Covaxin. But some AIIMS doctors in Delhi say they want to wait for the safety and efficacy data.
In the consent form, the Covaxin manufacturer said the compensation will be paid in case if the serious adverse effect is proven to be causally related to the vaccine.
Analysts say supply to government amid low distribution, marketing and R&D costs could aid profits. Bharat Biotech vaccine is priced at Rs 206 per dose while SII’s is at Rs 200.
Govt firm will buy vaccines from Serum Institute of India & Bharat Biotech and supply them to Nepal, Bangladesh, Sri Lanka, Afghanistan, Seychelles and Mauritius.
People's University of Bhopal, the trial site, denies the claim that participants have been kept in the dark about the nature of the exercise, and say all checks and balances are in place.
The immediate benefit of Single Tax would be to reduce the sale prices of land to nominal ones. Landowners would no longer find it profitable to keep idle lands, wrote DM Kulkarni in 1960.
It is argued that India-Israel ties are moving from buyer–seller dynamic to one focused on joint development & manufacturing partnership, a shift 'more durable' than traditional arms sales.
If Pathaan gave both conservatives and liberals room to hide, Dhurandhar extends no such courtesy. Aditya Dhar ripped open that tent of hypocrisy and turned the knife.
COMMENTS